Treatments and outcomes of encapsulating peritoneal sclerosis in patients undergoing peritoneal dialysis: 295 cases from a nationwide inpatient database in Japan.


Journal

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis
ISSN: 1718-4304
Titre abrégé: Perit Dial Int
Pays: United States
ID NLM: 8904033

Informations de publication

Date de publication:
11 2020
Historique:
pubmed: 11 6 2020
medline: 25 11 2021
entrez: 11 6 2020
Statut: ppublish

Résumé

The number of patients undergoing renal replacement therapy is increasing. We evaluated the practice patterns and outcomes of encapsulating peritoneal sclerosis (EPS) in patients undergoing peritoneal dialysis. Using a Japanese national inpatient database, we identified 295 patients with EPS who were hospitalized from July 2010 to March 2017. We categorized them into four groups: those who underwent surgery only ( More than half of patients were males and never-smokers and had a normal body mass index. Patients tended to undergo parenteral nutrition for 2 months. The proportions of emergency admission, intensive care unit (ICU) admission, central venous catheterization, catecholamine use, mechanical ventilation, and continuous hemodiafiltration were significantly different among the four groups (61%, 8.1%, 37.0%, 44.0%, 8.8%, and 5.8%, respectively). The both-treatment group had a significantly longer hospital stay (37.0 vs. 37.5 vs. 72.5 vs. 31.0 days, Our findings provide useful information for clinicians and patients hospitalized for treatment of EPS.

Sections du résumé

BACKGROUND
The number of patients undergoing renal replacement therapy is increasing. We evaluated the practice patterns and outcomes of encapsulating peritoneal sclerosis (EPS) in patients undergoing peritoneal dialysis.
METHODS
Using a Japanese national inpatient database, we identified 295 patients with EPS who were hospitalized from July 2010 to March 2017. We categorized them into four groups: those who underwent surgery only (
RESULTS
More than half of patients were males and never-smokers and had a normal body mass index. Patients tended to undergo parenteral nutrition for 2 months. The proportions of emergency admission, intensive care unit (ICU) admission, central venous catheterization, catecholamine use, mechanical ventilation, and continuous hemodiafiltration were significantly different among the four groups (61%, 8.1%, 37.0%, 44.0%, 8.8%, and 5.8%, respectively). The both-treatment group had a significantly longer hospital stay (37.0 vs. 37.5 vs. 72.5 vs. 31.0 days,
CONCLUSIONS
Our findings provide useful information for clinicians and patients hospitalized for treatment of EPS.

Identifiants

pubmed: 32519585
doi: 10.1177/0896860820930635
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

593-599

Auteurs

Takaaki Konishi (T)

Department of Breast and Endocrine Surgery, Graduate School of Medicine, 13143The University of Tokyo, Japan.
Department of Clinical Epidemiology and Health Economics, School of Public Health, 13143The University of Tokyo, Japan.

Michimasa Fujiogi (M)

Department of Clinical Epidemiology and Health Economics, School of Public Health, 13143The University of Tokyo, Japan.

Nobuaki Michihata (N)

Department of Health Services Research, Graduate School of Medicine, 13143The University of Tokyo, Japan.

Kojiro Morita (K)

Department of Clinical Epidemiology and Health Economics, School of Public Health, 13143The University of Tokyo, Japan.

Hiroki Matsui (H)

Department of Clinical Epidemiology and Health Economics, School of Public Health, 13143The University of Tokyo, Japan.

Kiyohide Fushimi (K)

Department of Health Policy and Informatics, 13143Tokyo Medical and Dental University Graduate School, Japan.

Masahiko Tanabe (M)

Department of Breast and Endocrine Surgery, Graduate School of Medicine, 13143The University of Tokyo, Japan.

Yasuyuki Seto (Y)

Department of Breast and Endocrine Surgery, Graduate School of Medicine, 13143The University of Tokyo, Japan.

Hideo Yasunaga (H)

Department of Clinical Epidemiology and Health Economics, School of Public Health, 13143The University of Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH